Skip to content
Intent.Health — AI That’s Natively Healthcare
INTENT.HEALTH / INSIGHTSAll resources ↗
Diagnostics & Oncology

Blood Test Added to U.S. Colorectal Cancer Screening Options

By Intent.Health Team • May 27, 2026
Intent Health AI Data Flow

What’s happening

A blood test was officially added as a recognized U.S. colorectal cancer screening option, significantly expanding medical alternatives to traditional colonoscopy-based screening protocols.

What’s changing / Business impact

The introduction of this non-invasive testing model opens up new market opportunities:

  • Easier cancer screening access across diverse patient populations
  • A potential increase in overall screening participation rates
  • Accelerated clinical expansion of non-invasive preventative diagnostics

Why this matters

Many individuals historically avoid critical colonoscopies because they are invasive, complex, and inconvenient.

This inclusion highlights how simpler testing options may radically improve early cancer detection, demonstrating that advanced diagnostics are becoming systematically more patient-friendly.

CORE TAKEAWAY

Healthcare innovation increasingly focuses not only on treatment, but also on making prevention easier and more accessible.

YOUR NEXT MOVE

Bring your market into focus.

See how organizations, people, clinical activity and intent come together for your team.

Explore your use case ↗